A second protease-activated receptor (PAR-2) that could be activated by try
psin or more physiologically by mast cell tryptase has been recently cloned
. Both the structure and activation mechanism of PAR-2 was similar to the f
unctional thrombin receptor (PAR-1). Although many effects of the coagulati
on protease thrombin on the vascular endothelium could be attributed to PAR
-1 activation, very little is known about the physiological and pathophysio
logical role of PAR-2. We investigated whether stimulation of PAR-2 on endo
thelial cells induced two cellular responses that play a central role in pr
imary and secondary haemostasis: the release of high molecular weight von W
illebrand factor (hmw-VWF) from Weibel-Palade bodies and the de novo synthe
sis of tissue factor (TF) mRNA and protein. Human umbilical vein endothelia
l cells (HUVEC) were incubated with agonists for PAR-2 at 37 degrees C. Bot
h trypsin and SLIGKV increased TF mRNA and activity and induced the release
of hmw-VWF due to elevated levels of cytosolic Ca2+. Trypsin (10 nM) induc
ed a 6-fold increase of TF mRNA and reduced time until fibrin clot formatio
n to 37%, indicating trebling of the cell surface located TF activity, Stim
ulation of HUVEC with the PAR-2 agonist peptide SLIGKV induced a dose-depen
dent increase of TF mRNA up to 6 times and TF activity up to 3 times. Relea
se of hmw-VWF was achieved both after incubation of HUVEC with trypsin and
SLIGKV and was directly depending on intracellular Ca2+ mobilization, To ma
ke results comparable to the functional thrombin receptor, homologous exper
iments were carried out using the PAR-1 agonists thrombin and SFLLRN.